首页> 外文期刊>Dermatologic surgery >Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study).
【24h】

Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study).

机译:不同注射剂的风险概况:注射剂安全性研究(IFS研究)的结果。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Injectable fillers are widely used in aesthetic medicine. Although most materials are considered to be safe, adverse events occur. Our knowledge on frequency and potential risk factors is limited. OBJECTIVE: The aim of this study was to describe adverse reactions to injectable fillers based on a partly population-based case series. METHODS: Dermatologists, plastic surgeons, and maxillofacial surgeons in Berlin were asked to report patients with adverse reactions. Additional patients were obtained from a private practice. A standardized questionnaire was used to assess all data. All data were analyzed by descriptive measures. RESULTS: Fifty-six patients (age, 48+/-11.2 (SD) years) who had been treated with nine different fillers were assessed. In 48 patients treated with only one filler, 167 areas had been treated. In 129 (77.3%) areas adverse reactions occurred 12.2+/-15.6 (SD) months after injection. Adverse reactions to biodegradable fillers occurred after 4.9+/-5.8 (SD) months, and reactions to nonbiodegradable fillers after 18.3+/-19.0 (SD) months (p=.005). As adverse events, continuing pain, swelling, nodules, pigmentation, abscess formation, and erythema were found. CONCLUSION: Adverse reactions can be documented for all injectable fillers. Time until reaction as well as type of reaction, however, vary between different fillers. Further research is necessary to evaluate potential risk factors.
机译:背景:可注射填充剂广泛用于美容医学。尽管大多数材料被认为是安全的,但仍会发生不良事件。我们对频率和潜在风险因素的了解有限。目的:本研究的目的是根据部分基于人群的病例系列描述对注射用填充剂的不良反应。方法:柏林的皮肤科医生,整形外科医生和颌面外科医生被要求报告有不良反应的患者。其他患者是从私人诊所获得的。使用标准化问卷调查表评估所有数据。通过描述性措施分析所有数据。结果:评估了接受过9种不同填充剂治疗的56例患者(年龄48 +/- 11.2(SD)岁)。在仅使用一种填充剂治疗的48例患者中,已经治疗了167个区域。注射后129个月(77.3%)出现不良反应,发生时间为12.2 +/- 15.6(SD)个月。在4.9 +/- 5.8(SD)个月后发生了对可生物降解填料的不良反应,在18.3 +/- 19.0(SD)个月后发生了对不可生物降解的填料的不良反应(p = .005)。作为不良事件,发现持续疼痛,肿胀,结节,色素沉着,脓肿形成和红斑。结论:所有可注射填充剂的不良反应均可记录在案。但是,在不同的填料之间,直到反应的时间以及反应的类型都不同。有必要进行进一步的研究以评估潜在的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号